Savior Lifetec Corporation's Injection Plant (IP) in Tainan, Taiwan Passes US FDA cGMP Audit

Savior Lifetec Corporation announced that the sterile parenteral drug manufacturing facility in Tainan, Taiwan has been granted "acceptable" status under the FDA's regulatory guidelines on December 29, 2014. The cGMP inspection by the US Food and Drug Administration (FDA) was completed during the period of June 16-20, 2014.